Skip to content
Announcement:

Latest Publication: Read our teams’ latest paper in Antibiotics, showing reduced nephrotoxicity of a novel formulation of polymyxin B compared to the clinical formulation using a validated primary human proximal tubule cell model.

WHY WE DO IT

Our purpose is to bridge the gap between scientific discovery and patients. We make a difference by providing better predictions of clinical outcomes.

Don't miss out on our latest innovations: follow us on Linkedin

Published

24th April, 2019

Categories

Update

Get our latest updates straight to your inbox